Ultragenyx Pharmaceutical | RARE - درآمد حاصل از بهره





درآمد حاصل از بهره تغییر دادن تاریخ
Acadia Pharmaceuticals USD 8.25M 1M 2025-09
Agios Pharmaceuticals USD 13.37M 1.14M 2025-09
Alnylam Pharmaceuticals USD 28.68M 1.19M 2025-09
BioCryst Pharmaceuticals USD -0.13 3.59M 2024-12
BioMarin Pharmaceutical USD 17.85M 973K 2025-09
Esperion Therapeutics USD -0.15 0.18 2024-09
Immunic USD -0.24 0.03 2024-09
Insmed USD 765K 55K 2024-09
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Karyopharm Therapeutics USD -0.15 0.11 2024-12
Kyowa Hakko Kirin JPY 2.54B 1.52B 2024-06
MacroGenics USD 1.53M 114K 2025-09
Moderna USD 73M 8M 2025-09
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 175.1M 300K 2025-09
Sarepta Therapeutics USD 8.38M 1.24M 2025-09
Ultragenyx Pharmaceutical USD 5.86M 69K 2025-09
Vertex Pharmaceuticals USD 125.7M 3.3M 2025-09